0.68 - 0.75
0.33 - 0.86
13.06M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
447.27%
Operating income growth of 447.27% while 0819.HK is zero. Bruce Berkowitz would see if this modest edge can become significant.
-240.38%
Negative net income growth while 0819.HK stands at 0.00%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-240.64%
Negative EPS growth while 0819.HK is at 2.70%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-240.64%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.29%
Share reduction while 0819.HK is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.29%
Reduced diluted shares while 0819.HK is at 0.82%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.29%
Dividend growth of 0.29% while 0819.HK is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
36886.77%
10Y revenue/share CAGR above 1.5x 0819.HK's 226.25%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
77774.65%
5Y revenue/share CAGR above 1.5x 0819.HK's 226.25%. David Dodd would look for consistent product or market expansions fueling outperformance.
49695.23%
3Y revenue/share CAGR above 1.5x 0819.HK's 101.94%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-1313.32%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-579.30%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-2099.45%
Negative 3Y OCF/share CAGR while 0819.HK stands at 116.83%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-993.88%
Negative 10Y net income/share CAGR while 0819.HK is at 170.42%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-1437.92%
Negative 5Y net income/share CAGR while 0819.HK is 170.42%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-678.14%
Negative 3Y CAGR while 0819.HK is 133.47%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
4.16%
AR growth of 4.16% while 0819.HK is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
35.28%
Inventory growth well above 0819.HK's 52.73%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
19.16%
Positive asset growth while 0819.HK is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
6.99%
Under 50% of 0819.HK's 29.86%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
10.37%
We have some new debt while 0819.HK reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.